Literature DB >> 23993229

Chromatin modulators as facilitating factors in cellular reprogramming.

Luis Luna-Zurita1, Benoit G Bruneau.   

Abstract

In the last few years, cellular reprogramming has emerged as a means to alter cellular identity and generate diverse cell types for disease modeling, drug testing, and potential therapeutic use. Since each cell type is a result of a specific gene expression profile finely regulated by the activity of a repertoire of transcription factors (TFs), reprogramming approaches have, thus far, been relatively inefficient and based largely on the forced expression of selective cell type-specific TFs. TFs function within the confines of chromatin, and the chromatin states can in turn be modulated by TF activity. Therefore, the knowledge of how chromatin remodeling factors alter chromatin structure, control TF activity and gene expression has led to an improved reprogramming efficiency and extended the number of cellular types that can be generated by cellular reprogramming. Here we review recent insights into the role and mechanisms by which chromatin remodeling, histone modifications, and DNA methylation contribute to cellular differentiation and reprogramming.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2013        PMID: 23993229     DOI: 10.1016/j.gde.2013.07.002

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  11 in total

1.  The START App: a web-based RNAseq analysis and visualization resource.

Authors:  Jonathan W Nelson; Jiri Sklenar; Anthony P Barnes; Jessica Minnier
Journal:  Bioinformatics       Date:  2017-02-01       Impact factor: 6.937

Review 2.  Establishing pluripotency in early development.

Authors:  Sarita S Paranjpe; Gert Jan C Veenstra
Journal:  Biochim Biophys Acta       Date:  2015-04-07

Review 3.  Stem cells for spinal cord injury: Strategies to inform differentiation and transplantation.

Authors:  Nisha R Iyer; Thomas S Wilems; Shelly E Sakiyama-Elbert
Journal:  Biotechnol Bioeng       Date:  2016-09-21       Impact factor: 4.530

Review 4.  Investigating the transcriptional control of cardiovascular development.

Authors:  Irfan S Kathiriya; Elphège P Nora; Benoit G Bruneau
Journal:  Circ Res       Date:  2015-02-13       Impact factor: 17.367

5.  Bmi1 Is a Key Epigenetic Barrier to Direct Cardiac Reprogramming.

Authors:  Yang Zhou; Li Wang; Haley Ruth Vaseghi; Ziqing Liu; Rui Lu; Sahar Alimohamadi; Chaoying Yin; Ji-Dong Fu; Greg G Wang; Jiandong Liu; Li Qian
Journal:  Cell Stem Cell       Date:  2016-03-03       Impact factor: 24.633

Review 6.  Cellular reprogramming for understanding and treating human disease.

Authors:  Riya R Kanherkar; Naina Bhatia-Dey; Evgeny Makarev; Antonei B Csoka
Journal:  Front Cell Dev Biol       Date:  2014-11-12

7.  Chd7 cooperates with Sox10 and regulates the onset of CNS myelination and remyelination.

Authors:  Danyang He; Corentine Marie; Chuntao Zhao; Bongwoo Kim; Jincheng Wang; Yaqi Deng; Adrien Clavairoly; Magali Frah; Haibo Wang; Xuelian He; Hatem Hmidan; Blaise V Jones; David Witte; Bernard Zalc; Xin Zhou; Daniel I Choo; Donna M Martin; Carlos Parras; Q Richard Lu
Journal:  Nat Neurosci       Date:  2016-02-29       Impact factor: 24.884

8.  High-Throughput Analysis of Global DNA Methylation Using Methyl-Sensitive Digestion.

Authors:  Hiromi Shiratori; Carmen Feinweber; Claudia Knothe; Jörn Lötsch; Dominique Thomas; Gerd Geisslinger; Michael J Parnham; Eduard Resch
Journal:  PLoS One       Date:  2016-10-17       Impact factor: 3.240

Review 9.  Cell replacement therapy for central nervous system diseases.

Authors:  Danju Tso; Randall D McKinnon
Journal:  Neural Regen Res       Date:  2015-09       Impact factor: 5.135

10.  A Loss of Function Screen of Epigenetic Modifiers and Splicing Factors during Early Stage of Cardiac Reprogramming.

Authors:  Yang Zhou; Sahar Alimohamadi; Li Wang; Ziqing Liu; Joseph B Wall; Chaoying Yin; Jiandong Liu; Li Qian
Journal:  Stem Cells Int       Date:  2018-03-18       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.